Research Article
[Retracted] Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
Table 3
Association of CYFRA21-1 with clinical data of NSCLC patients (n, %).
| Index | Relative expression of CYFRA21-1 | value | High expression (n = 30) | Low expression (n = 30) |
| Age | ≥60 years (n = 33) | 19 | 14 | 0.195 | <60 years (n = 27) | 11 | 16 | Gender | Male (n = 35) | 15 | 21 | 0.114 | Female (n = 24) | 15 | 9 | Tumour size | ≥3 cm (n = 30) | 12 | 18 | 0.121 | <3 cm (n = 30) | 18 | 12 | Clinical staging | I + II (n = 37) | 14 | 23 | | III + IV (n = 23) | 16 | 7 | Lymph node metastasis | Yes (n = 18) | 12 | 6 | 0.091 | None (n = 42) | 18 | 24 | Tumour type | Squamous cell carcinoma (n = 27) | 18 | 9 | | Adenocarcinoma (n = 33) | 12 | 21 |
|
|
Note. denotes a notable difference. |